Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022.

Cancer Gene Therapy Market Breast and Lung Cancer dominate, driven by high incidence and genetic testing integration. US, NY, UNITED ST ...

Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of ...

The following is a summary of "A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors ...

The global Osimertinib drugs market is on the verge of significant expansion, with an estimated rise in revenue from US$ 4,828.6 million in 2021 to US$ 11,829.8 million by 2027. This growth reflects a ...

Despite some moderation in 2023, the Philippine economy is projected to continue growing. The economy is expected to moderate to 5.9% in 2023 due to high base effects and weaker external demand before ...

Lung cancer is the commonest cancer worldwide ... Here we present a brief overview of the key tumor suppressors and driver oncogenes involved in NSCLC followed by a review of the most recent ...

In summary, another paradigm shift is needed to improve outcomes ... ECOG PS, Eastern Cooperative Oncology Group performance status; NSCLC, non–small cell lung cancer; ORR, overall response rate; OS, ...

Data shows Norway, which is similar in population size to NZ, increased its five-year survival rates for ovarian cancer from 34.1% to 46.1% in the almost two decades from 1995. In contrast, New ...

Contact Sokolove Law now to find out if you may be eligible for compensation from an asbestos lung cancer lawsuit. Play Video Video Summary: Sokolove Law Managing Attorney Ricky LeBlanc discusses the ...

Stage 3 non-small cell lung cancer (NSCLC) is lung cancer that has spread to nearby (regional) tissues. Stage 3 also has three sub-stages that give more details about how and where the cancer has ...